Relating to: designating April 2025 and April 2026 as Parkinsonâs Disease Awareness Months.
Impact
The designation of these months is intended to encourage further research, education, and community support for those affected by Parkinson's disease. The resolution recognizes the significant economic burden posed by the disease, which is estimated to exceed $52 billion annually due to both direct medical costs and indirect costs such as lost income. By promoting awareness, the resolution aims to foster a greater understanding of the disease and the necessities of improved care and treatment options. This initiative aligns with the efforts of various organizations dedicated to this cause, such as the Michael J. Fox Foundation.
Summary
AJR23 is an assembly joint resolution that aims to designate April 2025 and April 2026 as Parkinson's Disease Awareness Months in Wisconsin. This resolution seeks to raise awareness about Parkinson's disease, a chronic and progressive neurological disorder that significantly affects many individuals across the United States. With an estimated 1 million people currently diagnosed and projections indicating a rise to 1.2 million by 2030, the resolution stresses the pressing need to highlight the condition and its impact on patients and their families.
Contention
While AJR23 primarily serves to bring awareness, it has the potential to spark discussions regarding funding for medical research and the necessary support systems for individuals with Parkinson's disease. As there is currently no cure or reliable treatment to halt its progression, the resolution emphasizes the importance of increased support for community services and educational initiatives. This emphasis showcases a collaborative effort to improve the life quality for those grappling with Parkinson's disease and may lead to further legislative measures that could affect research financing and healthcare policies.